IFM Investors’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $6.6M | Buy |
33,859
+3,588
| +12% | +$744K | 0.04% | 347 |
|
|
2026
Q1 | $6.8M | Buy |
30,271
+1,293
| +4% | +$322K | 0.06% | 300 |
|
|
2025
Q4 | $6.98M | Buy |
28,978
+631
| +2% | +$161K | 0.06% | 288 |
|
|
2025
Q3 | $7.66M | Buy |
28,347
+98
| +0.3% | +$26.8K | 0.07% | 261 |
|
|
2025
Q2 | $7.29M | Buy |
28,249
+1,671
| +6% | +$399K | 0.07% | 262 |
|
|
2025
Q1 | $5.95M | Hold |
26,578
| – | – | 0.06% | 285 |
|
|
2024
Q4 | $6.08M | Sell |
26,578
-2,905
| -10% | -$699K | 0.06% | 292 |
|
|
2024
Q3 | $7.2M | Buy |
29,483
+31
| +0.1% | +$6.93K | 0.07% | 282 |
|
|
2024
Q2 | $5.64M | Sell |
29,452
-314
| -1% | -$63.7K | 0.06% | 317 |
|
|
2024
Q1 | $5.89M | Buy |
29,766
+504
| +2% | +$92.4K | 0.06% | 299 |
|
|
2023
Q4 | $5.03M | Hold |
29,262
| – | – | 0.06% | 303 |
|
|
2023
Q3 | $4.33M | Buy |
29,262
+914
| +3% | +$165K | 0.06% | 322 |
|
|
2023
Q2 | $6.19M | Sell |
28,348
-840
| -3% | -$187K | 0.08% | 258 |
|
|
2023
Q1 | $6.39M | Buy |
29,188
+795
| +3% | +$172K | 0.1% | 228 |
|
|
2022
Q4 | $5.91M | Buy |
28,393
+1,709
| +6% | +$375K | 0.1% | 229 |
|
|
2022
Q3 | $5.83M | Buy |
26,684
+737
| +3% | +$168K | 0.11% | 213 |
|
|
2022
Q2 | $5.44M | Buy |
25,947
+2,460
| +10% | +$524K | 0.1% | 222 |
|
|
2022
Q1 | $5.7M | Buy |
23,487
+3,810
| +19% | +$922K | 0.09% | 235 |
|
|
2021
Q4 | $5.13M | Buy |
19,677
+267
| +1% | +$69.3K | 0.09% | 213 |
|
|
2021
Q3 | $5.12M | Buy |
19,410
+105
| +0.5% | +$28.7K | 0.11% | 189 |
|
|
2021
Q2 | $4.76M | Buy |
19,305
+2,854
| +17% | +$600K | 0.1% | 214 |
|
|
2021
Q1 | $3.19M | Buy |
16,451
+2,522
| +18% | +$506K | 0.09% | 246 |
|
|
2020
Q4 | $2.96M | Buy |
13,929
+2,156
| +18% | +$430K | 0.09% | 214 |
|
|
2020
Q3 | $2.02M | Buy |
11,773
+952
| +9% | +$176K | 0.08% | 233 |
|
|
2020
Q2 | $2.08M | Sell |
10,821
-4,264
| -28% | -$698K | 0.11% | 186 |
|
|
2020
Q1 | $2.33M | Buy |
15,085
+1,110
| +8% | +$177K | 0.1% | 182 |
|
|
2019
Q4 | $2.17M | Sell |
13,975
-1,122
| -7% | -$162K | 0.08% | 269 |
|
|
2019
Q3 | $2.04M | Buy |
15,097
+4,351
| +40% | +$570K | 0.08% | 277 |
|
|
2019
Q2 | $1.31M | Buy |
10,746
+1,529
| +17% | +$169K | 0.07% | 285 |
|
|
2019
Q1 | $958K | Buy |
9,217
+609
| +7% | +$62.9K | 0.06% | 339 |
|
|
2018
Q4 | $980K | Buy |
8,608
+819
| +11% | +$87.7K | 0.08% | 253 |
|
|
2018
Q3 | $898K | Buy |
7,789
+1,003
| +15% | +$110K | 0.07% | 301 |
|
|
2018
Q2 | $703K | Buy |
6,786
+1,991
| +42% | +$201K | 0.07% | 317 |
|
|
2018
Q1 | $472K | Buy |
4,795
+369
| +8% | +$34.9K | 0.07% | 328 |
|
|
2017
Q4 | $375K | Hold |
4,426
| – | – | 0.06% | 387 |
|
|
2017
Q3 | $341K | Hold |
4,426
| – | – | 0.06% | 390 |
|
|
2017
Q2 | $345K | Buy |
4,426
+1,167
| +36% | +$83.5K | 0.06% | 375 |
|
|
2017
Q1 | $235K | Buy |
+3,259
| New | +$225K | 0.06% | 401 |
|
Other funds holding RMD
AT
DJSG
CIM
AC
MPWT
NAM
CNB
IFM Investors's RMD Position: Q2 2026 in Review
IFM Investors increased its ResMed (RMD) stake by 12% in Q2 2026, buying an estimated $744K and bringing the position to 33,859 shares worth $6.6M. The position accounts for 0.04% of the portfolio, ranked #347.
IFM Investors first reported a position in RMD in Q1 2017 and has held it in 38 quarters since. The position peaked at $7.66M in Q3 2025. 139 funds tracked by Wall St. Rank hold RMD as of Q2 2026.
- IFM Investors held 33,859 shares of ResMed worth $6.6M as of Q2 2026.
- IFM Investors bought 3,588 ResMed shares in Q2 2026, an estimated $744K.
- ResMed made up 0.04% of IFM Investors's portfolio in Q2 2026, its #347 holding.
- IFM Investors first reported a position in ResMed in Q1 2017 and has held it in 38 quarters since.
- IFM Investors's ResMed position peaked at $7.66M in Q3 2025.
- 139 funds tracked by Wall St. Rank held ResMed as of Q2 2026.
Based on IFM Investors's 13F filing for Q2 2026, filed 21 Jul 2026.